Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections
- PMID: 28367030
- PMCID: PMC5320877
- DOI: 10.4103/0974-2727.199639
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections
Abstract
Introduction: Stenotrophomonas maltophilia earlier had limited pathogenic potential, but now with growing degree of immunosuppression in general population, it is being recognized as an important nosocomial pathogen.
Methodology: A retrospective 7 years study was carried out to determine the clinical characteristics of all patients with Stenotrophomonas infections, antibiotic resistance pattern, and risk factors associated with hospital mortality. All patients with Stenotrophomonas culture positivity were identified and their medical records were reviewed. Risk factor associated with hospital mortality was analyzed.
Results: A total of 123 samples obtained from 88 patients were culture positive. Most patients presented with bacteremia (45, 51%) followed by pneumonia (37, 42%) and skin and soft tissue infections (6, 7%). About 23 of 88 Stenotrophomonas infected patients had co-infection. Percentage resistance to cotrimoxazole; 8 (5.4%) was lower than that for levofloxacin; 18 (12%). Twenty-eight patients died during hospital stay. Intensive Care Unit admission (P = 0.0002), mechanical ventilation (P = 0.0004), central venous catheterization (P = 0.0227), urethral catheterization (P = 0.0484), and previous antibiotic intake (P = 0.0026) were independent risk factors associated with mortality.
Conclusion: Our findings suggest that Stenotrophomonas can cause various infections irrespective of patient's immune status and irrespective of potential source. Thus, Stenotrophomonas should be thought of as potential pathogen and its isolation should be looked with clinical suspicion.
Keywords: Epidemiology; Stenotrophomonas; risk factors.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Clinical Characteristics and Prognostic Factors of Patients With Stenotrophomonas maltophilia Pneumonia: 10-Year Experience From a Single Center.Cureus. 2023 Oct 17;15(10):e47187. doi: 10.7759/cureus.47187. eCollection 2023 Oct. Cureus. 2023. PMID: 38021834 Free PMC article.
-
Stenotrophomonas maltophilia in Lower Respiratory Tract Infections.J Clin Diagn Res. 2014 Dec;8(12):DC20-2. doi: 10.7860/JCDR/2014/10780.5320. Epub 2014 Dec 5. J Clin Diagn Res. 2014. PMID: 25653948 Free PMC article.
-
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.J Microbiol Immunol Infect. 2004 Dec;37(6):350-8. J Microbiol Immunol Infect. 2004. PMID: 15599467
-
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.J Hosp Infect. 2012 Jun;81(2):114-8. doi: 10.1016/j.jhin.2012.02.008. Epub 2012 Apr 10. J Hosp Infect. 2012. PMID: 22494851
-
[A case-control study on the risk factors for lower respiratory tract infection by Stenotrophomonas maltophilia in a medical intensive care unit].Zhonghua Jie He He Hu Xi Za Zhi. 2011 Oct;34(10):735-8. Zhonghua Jie He He Hu Xi Za Zhi. 2011. PMID: 22321705 Chinese.
Cited by
-
Advances in the Microbiology of Stenotrophomonas maltophilia.Clin Microbiol Rev. 2021 Jun 16;34(3):e0003019. doi: 10.1128/CMR.00030-19. Epub 2021 May 26. Clin Microbiol Rev. 2021. PMID: 34043457 Free PMC article.
-
Clinical challenges treating Stenotrophomonas maltophilia infections: an update.JAC Antimicrob Resist. 2022 May 5;4(3):dlac040. doi: 10.1093/jacamr/dlac040. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35529051 Free PMC article. Review.
-
Efficacy in Galleria mellonella Larvae and Application Potential Assessment of a New Bacteriophage BUCT700 Extensively Lyse Stenotrophomonas maltophilia.Microbiol Spectr. 2023 Feb 14;11(1):e0403022. doi: 10.1128/spectrum.04030-22. Epub 2023 Jan 26. Microbiol Spectr. 2023. PMID: 36700630 Free PMC article.
-
Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion.BMC Infect Dis. 2020 Feb 1;20(1):99. doi: 10.1186/s12879-020-4793-6. BMC Infect Dis. 2020. PMID: 32007106 Free PMC article.
-
Resurgence of Global Opportunistic Multidrug-resistant Stenotrophomonas maltophilia.Indian J Crit Care Med. 2018 Jul;22(7):503-508. doi: 10.4103/ijccm.IJCCM_106_18. Indian J Crit Care Med. 2018. PMID: 30111925 Free PMC article.
References
-
- Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC. TSAR Hospitals. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect. 2012;45:120–6. - PubMed
-
- Xun M, Zhang Y, Li BL, Wu M, Zong Y, Yin YM. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in Northwest China. J Infect Dev Ctries. 2014;8:1000–5. - PubMed
-
- Naeem T, Absar M, Somily AM. Antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia at a teaching hospital in Riyadh, Saudi Arabia. J Ayub Med Coll Abbottabad. 2012;24:30–3. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources